Xiongfei Xu | Medicine and Dentistry | Excellence in Research

Posted on by ScienceFather

Dr. Xiongfei Xu | Medicine and Dentistry | Excellence in Research

Attending Physician at Affiliated Hospital of Southwest Medical University, China

Dr. Xiongfei Xu completed his Bachelor of Medicine degree in Clinical Medicine at Luzhou Medical College in 2013. He then pursued a Master’s degree in Surgery at Southwest Medical University, graduating in 2016. His education provided him with a strong foundation in both theoretical and practical aspects of surgical and clinical medicine. Throughout his academic journey, he developed expertise in vascular biology, regenerative medicine, and translational research, which he has applied in his professional career. Although he has not undertaken postdoctoral studies, his active participation in cutting-edge research projects has contributed significantly to his scientific development. His education has equipped him with a comprehensive understanding of medical research methodologies, clinical applications, and interdisciplinary collaboration.

Professional Profile

Professional Experience

Dr. Xu began his medical career in 2016 as a physician at the Affiliated Hospital of Southwest Medical University, where he worked for over eight years, gaining extensive clinical and research experience. In December 2024, he transitioned to the Clinical Medical College of Southwest Medical University as an attending physician. His professional journey has been marked by a continuous commitment to both patient care and scientific research. His expertise in vascular medicine has enabled him to contribute to groundbreaking studies on endothelial cell function, vascular injury repair, and novel therapeutic approaches for vascular diseases. Dr. Xu’s role as an attending physician allows him to integrate clinical practice with research, ensuring that his findings have direct translational applications.

Research Interests

Dr. Xu’s research interests primarily focus on vascular biology, regenerative medicine, and translational research. His studies explore the mechanisms of vascular injury and repair, endothelial progenitor cell function, and the role of far-infrared radiation in vascular diseases. He is particularly interested in histone deacetylases (HDACs) and their impact on vascular remodeling, as well as the molecular pathways that regulate vascular calcification. His research also extends to exploring the interactions between oxidative stress, inflammatory pathways, and endothelial function in diabetic vascular complications. By investigating novel therapeutic strategies, Dr. Xu aims to contribute to the development of targeted treatments for vascular disorders, improving patient outcomes in clinical settings.

Research Skills

Dr. Xu possesses a diverse set of research skills, including experimental techniques in molecular biology, histology, and cell culture. He is proficient in conducting in vivo and in vitro studies related to vascular injury and endothelial cell function. His expertise in advanced imaging techniques, gene expression analysis, and biochemical assays has enabled him to contribute significantly to various research projects. Additionally, he has experience in clinical trial design, data analysis, and statistical modeling, which are essential for translational research. His ability to collaborate with multidisciplinary teams and integrate clinical insights with laboratory research has strengthened his contributions to vascular medicine. Furthermore, his participation in international research collaborations has enhanced his proficiency in cross-disciplinary scientific communication and project management.

Awards and Honors

Although Dr. Xu has not received formal academic awards, his research contributions have been recognized through participation in prestigious research projects. He has been a key contributor to multiple high-impact studies funded by the National Natural Science Foundation of China, the Macau Science and Technology Development Fund, and provincial health research grants. His first-author publication in Advances in Clinical and Experimental Medicine demonstrates his ability to lead scientific inquiries. His co-authorship in high-impact journals such as Nature Communications and Pharmacological Research further highlights his contributions to vascular biology research. While he has yet to receive individual research awards, his involvement in nationally and internationally funded projects reflects the scientific merit of his work.

Conclusion

Dr. Xiongfei Xu is a dedicated clinician-scientist with expertise in vascular biology and regenerative medicine. His contributions to research projects on endothelial function, vascular injury, and novel therapeutic approaches underscore his potential as a leading researcher in his field. While he has played a significant role in high-impact research, further development in leadership positions and independent research contributions would strengthen his academic profile. Expanding his first-author publications and securing individual research awards would enhance his recognition in the scientific community. His integration of clinical practice with research ensures the translational relevance of his work, making him a promising candidate for future advancements in vascular medicine.

 

Khaled Saad | Medicine and Dentistry | Excellence in Research

Posted on by ScienceFather

Prof. Dr. Khaled Saad | Medicine and Dentistry | Excellence in Research

Professor of Pediatrics at Assiut University, Egypt

Dr. Khaled Saad is a distinguished Professor of Pediatrics at Assiut University in Egypt, with a career spanning over two decades. He has made significant contributions to pediatric medicine through his extensive research, numerous publications, and active involvement in various professional organizations. His dedication to advancing pediatric care and education has earned him recognition both nationally and internationally.

Professional Profile

Education:

Dr. Saad completed his Bachelor of Medicine and Surgery (MBBCH) at Assiut University in 1997, graduating with honors. He pursued further specialization by obtaining a Master’s degree in Pediatrics in 2003, followed by a Ph.D. in Pediatrics in 2009. During his doctoral studies, he collaborated with esteemed institutions such as Ain Shams University and the National Research Center in Cairo, Egypt.

Professional Experience:

Dr. Saad’s professional journey includes roles as an Assistant Lecturer and Assistant Professor in Pediatrics at Assiut University, where he has been instrumental in teaching and mentoring medical students and residents. Since 2016, he has served as a Consultant of Pediatrics and Head of the Pediatric Department at Madinah National Hospital in Saudi Arabia. His leadership has been pivotal in establishing the pediatric neurology clinic and EEG unit, enhancing pediatric care services in the region.

Research Interests:

Dr. Saad’s research focuses on pediatric neuropsychiatry, autism, and attention-deficit/hyperactivity disorder (ADHD). He has authored over 120 publications and contributed to five book chapters, reflecting his commitment to advancing knowledge in these areas. His work has been published in reputable journals, underscoring his influence in pediatric research.

Research Skills:

Dr. Saad possesses advanced research skills, including study design, data analysis, and manuscript preparation. His extensive publication record and editorial roles demonstrate his proficiency in disseminating research findings. He has supervised numerous theses and actively participates in organizing scientific conferences, highlighting his dedication to fostering research excellence.

Awards and Honors:

While specific awards and honors are not detailed in the available information, Dr. Saad’s significant contributions to pediatric medicine and research have been recognized through his leadership roles, editorial positions, and active participation in professional organizations. His work continues to impact the field of pediatrics positively.

Conclusion:

Dr. Khaled Saad’s extensive education, professional experience, and dedication to pediatric research and education underscore his significant contributions to the field. His leadership in establishing specialized pediatric services and his active involvement in academic and professional communities reflect his commitment to advancing pediatric care and knowledge. Dr. Saad’s work continues to inspire and influence the next generation of pediatricians and researchers.

Publication Top Notes

  • The role of probiotics in children with autism spectrum disorder: A prospective, open-label study
    • Authors: SY Shaaban, YG El Gendy, NS Mehanna, WM El-Senousy, HSA El-Feki, et al.
    • Year: 2018
    • Citations: 367
    • Journal: Nutritional Neuroscience, Volume 21, Issue 9, Pages 676-681
    • DOI: 10.1080/1028415X.2018.1460190
    • Summary: This study investigates the effects of probiotics on behavioral and gastrointestinal symptoms in children with autism spectrum disorder (ASD). The results suggest that probiotics may have beneficial effects on both behavioral and gastrointestinal manifestations of ASD.
  • Prevalence of symptoms of asthma, rhinitis, and eczema in 13‐to 14‐year‐old children in Africa: The International Study of Asthma and Allergies in Childhood Phase III
    • Authors: N Ait‐Khaled, J Odhiambo, N Pearce, KS Adjoh, IA Maesano, et al.
    • Year: 2007
    • Citations: 338
    • Journal: Allergy, Volume 62, Issue 3, Pages 247-258
    • DOI: 10.1111/j.1398-9995.2007.01325.x
    • Summary: This study examines the prevalence of asthma, rhinitis, and eczema symptoms among 13- to 14-year-old children across various African countries. The findings highlight significant variations in the prevalence of these symptoms across different regions in Africa.
  • Timing of surgery following SARS‐CoV‐2 infection: An international prospective cohort study
    • Authors: COVIDSurg Collaborative, GlobalSurg Collaborative, D Nepogodiev, et al.
    • Year: 2021
    • Citations: 302
    • Journal: Anaesthesia, Volume 76, Issue 6, Pages 748-758
    • DOI: 10.1111/anae.15458
    • Summary: This international prospective cohort study investigates the optimal timing for elective surgery following SARS-CoV-2 infection. The study provides evidence to guide clinical decision-making regarding the timing of elective surgeries post-infection.
  • Vitamin D Status in Autism Spectrum Disorders and the Efficacy of Vitamin D Supplementation in Autistic Children
    • Authors: Not specified in the provided information.
    • Year: 2016
    • Citations: 284
    • Journal: Nutritional Neuroscience, Volume 19, Issue 8, Pages 346-351
    • Summary: This article explores the relationship between vitamin D levels and autism spectrum disorders, as well as the potential benefits of vitamin D supplementation in children with autism.
  • Oxidative Stress in Autism Spectrum Disorder
    • Authors: G Bjørklund, NA Meguid, MA El-Bana, AA Tinkov, K Saad, M Dadar, et al.
    • Year: 2020
    • Citations: 252
    • Journal: Molecular Neurobiology, Volume 57, Pages 2314-2332
    • Summary: This review discusses the role of oxidative stress in the pathophysiology of autism spectrum disorder, highlighting potential mechanisms and therapeutic approaches.
  • Immune Dysfunction and Neuroinflammation in Autism Spectrum Disorder
    • Authors: G Bjorklund, K Saad, S Chirumbolo, J Kern, D Geier, M Geier, M Urbina
    • Year: 2016
    • Citations: 205
    • Journal: Acta Neurobiologiae Experimentalis, Volume 76, Issue 4, Pages 257-268
    • Summary: This article examines the evidence for immune system dysfunction and neuroinflammation in individuals with autism spectrum disorder, suggesting potential pathways for intervention.
  • Effect of Hydroxyurea Treatment on the Inflammatory Markers Among Children with Sickle Cell Disease
    • Authors: AM Zahran, A Nafady, K Saad, HF Hetta, AEM Abdallah, SM Abdel-Aziz, et al.
    • Year: 2020
    • Citations: 195
    • Journal: Clinical and Applied Thrombosis/Hemostasis, Volume 26, Article 1076029619895111
    • Summary: This study investigates the impact of hydroxyurea treatment on inflammatory markers in children with sickle cell disease, providing insights into its therapeutic effects.

Vaibhav Sharma | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Vaibhav Sharma | Medicine and Dentistry | Best Researcher Award

Clinical Observer at St. Louis Heart and Vascular, St. Louis, MO, United States

Vaibhav Sharma is a dedicated medical graduate with a strong foundation in clinical practice and research. With two years of patient care experience, he has developed a keen eye for detailed medical assessments and accurate documentation. His leadership in innovative health screening projects demonstrates his commitment to improving healthcare outcomes. Vaibhav is passionate about advancing medicine through evidence-based practices and interdisciplinary collaboration, combining his expertise in patient care with a drive for continuous learning and research. Aspiring to a respected academic position, he seeks to contribute to healthcare advancement through impactful research and clinical practice, aiming to make a meaningful difference in patient care and medical progress.

Professional Profile

Education

Vaibhav Sharma completed his MBBS from the Armed Forces Medical College (AFMC), Pune, India, from August 2017 to February 2024. He consistently ranked among the top 10% of his class, excelling in subjects like Pharmacology, Microbiology, Ophthalmology, Otorhinolaryngology, and Pediatrics. He has successfully passed USMLE Step 1 and Step 2 CK, achieving a high score of 271 in Step 2 CK, placing him in the 98th percentile. He also holds impressive scores in the TOEFL (115/120) and the Occupational English Test, showcasing his strong command over the English language. His academic background is marked by a solid blend of clinical skills and theoretical knowledge, laying a strong foundation for his future endeavors in the medical field.

Professional Experience

Vaibhav Sharma’s professional journey includes a Visiting Scholar role at the University of Texas Health in Houston, where he immersed himself in advanced heart failure and heart transplant care. His experience extends to an observership at Christian Hospital in St. Louis, Missouri, where he enhanced his understanding of interventional cardiology and electrophysiology. Prior to this, he completed an externship at the Heart and Vascular Institute in Detroit, Michigan, focusing on cardiovascular health management and patient care efficiency. He also served as a Research Analyst at Panscience Innovations, where he led the development of an AI-based software aimed at improving clinical operations. Vaibhav’s clinical internship at Command Hospital, Pune, provided hands-on experience across various specialties, allowing him to contribute to rural health screening projects and develop efficient screening interventions for lifestyle diseases.

Research Interest

Vaibhav Sharma’s research interests lie at the intersection of clinical medicine and innovative health technologies. He is passionate about exploring cardiovascular diseases, particularly focusing on heart failure, arrhythmias, and myocardial conditions. His projects have included screening interventions for hematological abnormalities and lifestyle diseases in rural populations, emphasizing early detection and preventive care. Vaibhav is also interested in the role of lipid profiles in the progression of diabetic retinopathy, as well as the genetic basis of stress-induced ventricular arrhythmias. He aims to integrate emerging technologies, such as AI and machine learning, into clinical research to enhance diagnostic accuracy and treatment outcomes. His research reflects a commitment to advancing evidence-based practices and improving patient care through rigorous scientific inquiry.

Research Skills

Vaibhav Sharma possesses a robust set of research skills that enable him to conduct thorough and impactful studies. He is proficient in designing and executing clinical surveys, as demonstrated in his rural welfare research on myeloma screening and lifestyle disease prevention. His experience includes data collection, statistical analysis, and interpretation of complex clinical data, skills that he has applied in projects such as his lipid profile study on diabetic retinopathy patients. Vaibhav is also skilled in using electronic medical record (EMR) systems like EPIC for research purposes, ensuring accurate data management. Additionally, he has a strong background in preparing manuscripts for publication, contributing to peer-reviewed journals. His ability to collaborate with multidisciplinary teams and present research findings effectively makes him a valuable contributor to the scientific community.

Awards and Honors

Vaibhav Sharma has earned several awards and recognitions throughout his academic and professional journey. He received a prestigious research grant from the Indian Council of Medical Research (ICMR) for his study on the lipid profile in diabetic retinopathy patients. He was also acknowledged by the state government for his rural welfare project, which received a “Mega Project” status and a sponsorship of INR 1,00,00,000. In addition, Vaibhav has been recognized for his academic excellence, consistently ranking in the top 10% of his class at AFMC, Pune, and securing honors in multiple medical disciplines. He has also received accolades for his contributions to clinical presentations, such as his case presentation on bisalbuminemia at the American College of Physicians – India Chapter. His achievements reflect his dedication to medical research, academic excellence, and community-focused healthcare initiatives.

Conclusion

Vaibhav Sharma is a promising candidate for the Best Researcher Award, with strengths in conducting impactful research, receiving grants, and integrating clinical experience with research insights. His strong academic background and contributions to the field of cardiology and community health research are commendable. By focusing on long-term studies, enhancing his publication record, and narrowing his research focus, he can further strengthen his candidacy. His passion for continuous learning and medical advancement makes him a valuable asset to the research community.

Publications Top Notes

  1. SAICR‐CTO: Single Access Impella‐Guided Complete Revascularization in Chronic Total Occlusion—A Novel Approach to High‐Risk PCI
    • Journal: Catheterization and Cardiovascular Interventions
    • Year: 2024-10-22
    • DOI: 10.1002/ccd.31277
    • Contributors: Vaibhav Sharma, Abishek Arokiadoss, Anjali Bhardwaj, Shariq Shamim
  2. Comparison between Amino Acid Profiling of Structural Proteins of Earliest and Recent Omicron Strain of SARS-CoV-2 and Nutritional Burden on COVID-19 Patients
    • Journal: Human Nutrition & Metabolism
    • Year: 2023-12
    • DOI: 10.1016/j.hnm.2023.200220
    • Contributors: Vivek Ambade, Sonia Ambade, Vaibhav Sharma, Prasanna Sanas
  3. Normative Data of Beta-2-Microglobulin and Plasma Proteins from an Agrarian Indian Community By a Door-to-Door Survey: Results of Simple (IMAGe-002B) Study
    • Journal: Blood
    • Year: 2023-11-02
    • DOI: 10.1182/blood-2023-191125
    • Contributors: Yash Vashishth, Uday Yanamandra, Saurabh Bobdey, Vaibhav Sharma, V K Bhatti, J Muthukrishnan, Pankaj Malhotra, Velu Nair
  4. Prevalence of MGUS in Rural Indian Population: Results of Simple (IMAGe-002A) Study
    • Journal: Blood
    • Year: 2023-11-02
    • DOI: 10.1182/blood-2023-189661
    • Contributors: Celine Raphael, Uday Yanamandra, Saurabh Bobdey, Vaibhav Sharma, V K Bhatti, J Muthukrishnan, Pankaj Malhotra, Velu Nair

 

 

Isabella Colonna | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Dr. Isabella Colonna | Medicine and Dentistry | Best Researcher Award

MD, PhD at ASL Lecce, Ospedale Ferrari – Casarnao, Italy.

Dr. Isabella Colonna, MD, PhD, is a highly skilled neurologist with a deep specialization in epilepsy. She serves as the head of the EEG/Epilepsy Unit at the Neurology Department of “F. Ferrari” Hospital in Casarano, ASL Lecce, Italy. With nine years of experience, Dr. Colonna has significantly contributed to both clinical practice and research in neurology. She has a robust academic background, having earned her medical degree with honors from the University of Rome Tor Vergata, followed by her PhD focusing on neuroimaging in Alzheimer’s Disease. Her involvement with the European Academy of Neurology (EAN) as a representative on the Communication Committee and her role as an EAN Brain Health Ambassador underscore her commitment to advancing neurological health awareness across Europe. Dr. Colonna’s work in promoting brain health and collaboration between neurological societies, political institutions, and patient organizations is widely recognized, positioning her as a leader in the field.

Professional Profile

Education

Dr. Isabella Colonna graduated cum laude in Medicine from the University of Rome Tor Vergata in 2014, achieving a score of 110/110. She further expanded her education through an Erasmus program at the Medical University of Regensburg, Germany, in 2012-2013. After obtaining her medical degree, she pursued a residency in Neurology at the Medical University of Graz, Austria, which she completed in 2021. During her residency, she engaged in clinical training and research, culminating in a PhD with a focus on “Magnetization Transfer Imaging: A Non-Conventional MRI Technique for Longitudinal Assessment of Alzheimer’s Disease.” Recognized for her expertise, Dr. Colonna also earned a Neurosonology Certification from the General Medical Council of Austria in 2021. Additionally, she completed a Master’s degree in Neurophysiology at the Medical University of Bologna from 2023 to 2024, which further strengthened her skills in the field.

Professional Experience

Dr. Isabella Colonna’s professional journey reflects her dedication to clinical neurology and research. Since 2023, she has been leading the EEG/Epilepsy Unit at the “F. Ferrari” Hospital in Casarano, ASL Lecce, Italy. Prior to this role, she served as a neurologist in various hospitals across Southern Italy, including the “A. Perrino” Hospital in Brindisi and the IRCCS Maugeri di Bari, where she gained extensive experience in treating neurological disorders. From 2015 to 2021, Dr. Colonna was a neurology resident at the Medical University of Graz, Austria, where she honed her skills in neuroimaging and patient care. During this time, she also served as a teaching assistant at the university, sharing her knowledge with students. Her professional experience extends to her involvement with the European Academy of Neurology (EAN), where she has played a key role in communication efforts and advocacy for brain health.

Research Interest

Dr. Isabella Colonna’s research interests are centered on advancing the understanding of neurological disorders, particularly through neuroimaging and epilepsy research. Her PhD research focused on “Magnetization Transfer Imaging” as a method for tracking changes in Alzheimer’s disease over time, highlighting her interest in non-conventional MRI techniques. Her work aims to improve the diagnosis and management of Alzheimer’s and other neurodegenerative conditions through advanced imaging methods. Additionally, she is passionate about improving patient outcomes in epilepsy, which aligns with her current role as the head of the EEG/Epilepsy Unit at “F. Ferrari” Hospital. Dr. Colonna is also deeply committed to brain health awareness and policy-making, as evidenced by her involvement in the European Academy of Neurology’s (EAN) initiatives. Her research contributions, such as a recent study on the role of neurological societies in promoting brain health in Europe, underscore her dedication to bridging clinical practice with innovative research.

Research Skills

Dr. Isabella Colonna possesses a diverse set of research skills that have contributed to her success in the field of neurology. She is proficient in advanced neuroimaging techniques, including Magnetization Transfer Imaging (MTI), which she utilized during her PhD research to study Alzheimer’s disease progression. Her expertise extends to neurophysiology, as evidenced by her leadership of the EEG/Epilepsy Unit at “F. Ferrari” Hospital, where she applies her skills in electroencephalography (EEG) for the diagnosis and management of epilepsy. Dr. Colonna is also experienced in conducting clinical research, having completed multiple projects that have led to publications in reputable journals. Her work with the European Academy of Neurology (EAN) has further developed her skills in survey-based research, focusing on brain health awareness. Additionally, she has experience as a reviewer and abstract evaluator for the EAN, contributing her expertise to the advancement of neurological research.

Awards and Honors

Throughout her career, Dr. Isabella Colonna has received numerous awards and honors, reflecting her outstanding contributions to the field of neurology. In 2019, she was awarded the “Young Investigator Award” by the Austrian Alzheimer Association (Österreichische Alzheimer Gesellschaft) for her research on neuroimaging in Alzheimer’s disease. The same year, she received a bursary from the European Academy of Neurology (EAN) for her participation in the 5th EAN Congress in Oslo, Norway. Dr. Colonna’s commitment to advancing brain health awareness was further recognized in 2024, when she was named an EAN “Brain Health Ambassador.” Her involvement with the EAN also includes roles as a representative on the eCommunication Board and Communication Committee, where she has contributed to shaping the dialogue around neurological health. These accolades highlight her leadership, expertise, and dedication to improving neurological care and research on both national and European levels.

Conclusion

Isabella Colonna is a strong candidate for the Best Researcher Award. Her contributions to neurology, particularly in neuroimaging and epilepsy, her active involvement in professional societies, and her research accomplishments make her well-suited for this recognition. Strengthening her international collaborations and focusing on innovation could further bolster her profile for such prestigious awards.

Publications Top Notes

  1. Cortical laminar necrosis due to hypoglycemia in anti-CV2/CRMP5 paraneoplastic encephalitis: a curious association
    • Authors: Altomare, S., Colonna, I., Leone, R., Giorelli, M.
    • Year: 2024
    • Citations: 0
    • Journal: Acta Neurologica Belgica, 124(4), pp. 1405–1408.
  2. Sex steroid hormones and epilepsy: Effects of hormonal replacement therapy on seizure frequency of postmenopausal women with epilepsy—A systematic review
    • Authors: Carvalho, V., Colonna, I., Curia, G., Vonck, K., Zedde, M.
    • Year: 2023
    • Citations: 2
    • Journal: European Journal of Neurology, 30(9), pp. 2884–2898.
  3. Bringing door-to-needle times within the European benchmarks results in better stroke patients outcomes in a spoke hospital from the Apulian Region
    • Authors: Giorelli, M., Leone, R., Aniello, M.S., Tatò, E., Scelzi, A.
    • Year: 2023
    • Citations: 1
    • Journal: Neurological Sciences, 44(9), pp. 3199–3207.
  4. Serum levels of IL-6 are associated with cognitive impairment in the salus in apulia population-based study
    • Authors: Griseta, C., Battista, P., Castellana, F., Minafra, B., Sardone, R.
    • Year: 2023
    • Citations: 6
    • Journal: Heliyon, 9(3), e13972.
  5. Clinico-genetic spectrum of limb-girdle muscular weakness in Austria: A multicentre cohort study
    • Authors: Krenn, M., Tomschik, M., Wagner, M., Löscher, W.N., Cetin, H.
    • Year: 2022
    • Citations: 4
    • Journal: European Journal of Neurology, 29(6), pp. 1815–1824.
  6. Predicting atrial fibrillation after cryptogenic stroke via a clinical risk score—a prospective observational study
    • Authors: Kneihsl, M., Bisping, E., Scherr, D., Enzinger, C., Gattringer, T.
    • Year: 2022
    • Citations: 22
    • Journal: European Journal of Neurology, 29(1), pp. 149–157.
  7. Microstructural tissue changes in Alzheimer disease brains: Insights from magnetization transfer imaging
    • Authors: Colonna, I., Koini, M., Pirpamer, L., Schmidt, R., Ropele, S.
    • Year: 2021
    • Citations: 6
    • Journal: American Journal of Neuroradiology, 42(4), pp. 688–693.
  8. Neuropsychiatric symptoms differently affect mild cognitive impairment and Alzheimer’s disease patients: a retrospective observational study
    • Authors: Scaricamazza, E., Colonna, I., Sancesario, G.M., Mercuri, N.B., Liguori, C.
    • Year: 2019
    • Citations: 30
    • Journal: Neurological Sciences, 40(7), pp. 1377–1382.
  9. Cognitive Deficits and Related Brain Lesions in Patients With Chronic Heart Failure
    • Authors: Frey, A., Sell, R., Homola, G.A., Störk, S., Stoll, G.
    • Year: 2018
    • Citations: 74
    • Journal: JACC: Heart Failure, 6(7), pp. 583–592.
  10. Abnormal blood flow on transcranial duplex sonography predicts poor outcome after stroke thrombectomy
    • Authors: Kneihsl, M., Niederkorn, K., Deutschmann, H., Fazekas, F., Gattringer, T.
    • Year: 2018
    • Citations: 18
    • Journal: Stroke, 49(11), pp. 2780–2782.

 

Royston Liew | Medicine and Dentistry | Best Researcher Award

Posted on by ScienceFather

Mr. Royston Liew | Medicine and Dentistry | Best Researcher Award

Student at Duke-NUS Medical School, Singapore

Dr. Liew Yew Meng Royston is an emerging researcher with a background in Chemical and Biomolecular Engineering, focusing on the molecular mechanisms underlying Hepatocellular Carcinoma (HCC), particularly in None-B-None-C HCC patients. His research integrates engineering principles with biological sciences, offering a novel approach to understanding complex disease pathways, such as bile acid homeostasis. Dr. Royston is proactive in his research endeavors, having initiated wet-lab experiments months in advance under the guidance of Professor Pierce Chow. His work has led to significant findings in the role of post-translational modifications in liver-gut homeostasis. In addition to his research, Dr. Royston has been recognized for his innovation with multiple patents and awards, including the National Runner-Up in the James Dyson Award for his work in vertical farming. His interdisciplinary approach and commitment to advancing medical research make him a promising figure in the field of oncology and biomedical engineering.

Profile

Education

Dr. Liew Yew Meng Royston holds a Bachelor of Engineering (Honours) in Chemical and Biomolecular Engineering from Nanyang Technological University, Singapore, where he studied from 2018 to 2022. His academic training provided a strong foundation in engineering principles, which he has effectively applied to his research in the biomedical field. During his undergraduate studies, Dr. Royston demonstrated a keen interest in integrating engineering with biological systems, laying the groundwork for his current research in Hepatocellular Carcinoma (HCC). His educational journey was marked by academic excellence, earning him a place on the Dean’s List for the 2018/2019 academic year. The interdisciplinary nature of his education has equipped Dr. Royston with the skills to approach complex biological problems with precision and innovation, making significant contributions to his field. His commitment to academic and research excellence continues to drive his pursuit of advanced knowledge in medicine and biomedical engineering.

Professional Experience

Dr. Liew Yew Meng Royston has demonstrated considerable professional experience in both research and innovation. He is currently focused on Hepatocellular Carcinoma (HCC) research, specifically None-B-None-C HCC (NBNC HCC), where he applies his background in chemical and biomolecular engineering to investigate bile acid homeostasis and its implications for liver function. Before beginning his Duke-NUS Phase 3 Scholarly Research Project, Dr. Royston proactively engaged in preliminary research with Professor Pierce Chow, resulting in significant novel findings. His research approach integrates engineering principles with biological systems, employing techniques such as molecular pathway modeling and process optimization. Beyond his research, Dr. Royston has made notable contributions to the field of vertical farming, with a patent for a modular hydroponic system and recognition through awards like the James Dyson Award and the APAC CEO of the Year Awards. His expertise reflects a blend of scientific rigor and innovative problem-solving.

Research Interest

Dr. Liew Yew Meng Royston’s research interest centers on elucidating the molecular and cellular mechanisms underlying Hepatocellular Carcinoma (HCC), specifically focusing on None-B-None-C Hepatocellular Carcinoma (NBNC HCC). His work involves investigating the dysregulation of bile acid homeostasis pathways and their impact on liver function in NBNC HCC patients. By applying principles from Chemical and Biomolecular Engineering, Dr. Royston integrates metabolomic, microbiomic, and transcriptomic data to identify critical alterations in disease mechanisms. His research explores the role of post-translational modifications, particularly acetylation of the FXR protein, in influencing bile acid production and liver-gut homeostasis. Additionally, he investigates the effects of highly processed diets on the microbiome and their subsequent role in HCC development. Dr. Royston’s interdisciplinary approach aims to deepen understanding of HCC and develop innovative strategies for its treatment, blending engineering precision with advanced biological research.

Research Skills

Dr. Liew Yew Meng Royston possesses a diverse skill set tailored to his research in Hepatocellular Carcinoma (HCC). His skills include advanced techniques in metabolomics, microbiomics, and transcriptomics, which are essential for analyzing complex biological data. Dr. Royston is proficient in molecular pathway modeling and process optimization, applying engineering principles to biological systems. His expertise extends to wet-lab experimentation, including the study of post-translational modifications of proteins and their effects on gene transcription. Additionally, Dr. Royston employs systems-level approaches to integrate various biological and biochemical data, enhancing the precision and depth of his research. His proactive approach to research, demonstrated by initiating preliminary work and securing foundational results, further highlights his commitment and technical capabilities in addressing complex biomedical challenges.

Award and Recognition

Dr. Liew Yew Meng Royston has received significant recognition for his contributions to research and innovation. Notably, he was awarded the National Runner-Up position in the James Dyson Award in 2022 for his work on vertical farming, highlighting his innovative approach to urban agriculture. His invention of a modular hydroponic farming apparatus was patented internationally, underscoring his inventive capabilities. In addition to these achievements, Dr. Royston received the APAC CEO of the Year Awards for Most Innovative Agribusiness CEO in 2022, reflecting his impact on the agribusiness sector. His research efforts have also been supported by several grants, including the SSG Tech POC Grant of $250,000 and the SSG Founder’s Startup Grant of $50,000. Dr. Royston’s academic excellence was recognized through his inclusion on the Dean’s List at Nanyang Technological University for the academic year 2018/2019, further attesting to his dedication and outstanding performance in his field.

Conclusion

Liew Yew Meng Royston demonstrates significant potential as a researcher with a strong interdisciplinary approach and innovative mindset. His proactive research efforts, combined with his engineering background, position him as a promising candidate for the Best Researcher Award. However, enhancing his publication record and securing research grants could further solidify his standing in the research community.

Publication Top Notes

Diagnostic laparoscopy for pre-operative selection of patients with known peritoneal carcinomatosis for CRS-HIPEC: A systematic review and meta-analysis

  • Authors: Ang, A.J.Y., Liew, R.Y.M., Aw, V.Z.J., Chia, C.S., Shannon, N.B.
  • Year: 2024
  • Journal: European Journal of Surgical Oncology
  • Volume: 50
  • Issue: 11
  • Article Number: 108623